List of Allergan patents

Patents where

Current Assignee

Name

Allergan

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11344561 Treatment of submental fat		Allergan	Allergan	United States Patent and Trademark Office	11344561	May 31, 2022
‌ US Patent 10555900 Formulations and methods for vaginal delivery of antiprogenstins	Patent 10555900 was granted and assigned to Allergan on February, 2020 by the United States Patent and Trademark Office.	Repros Therapeutics Inc (Zonn)	Allergan	United States Patent and Trademark Office	10555900	February 11, 2020
‌ US Patent 11311516 Opioid receptor modulator dosage formulations	Patent 11311516 was granted and assigned to Allergan on April, 2022 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	11311516	April 26, 2022
‌ US Patent 11484527 Opioid receptor modulator dosage formulations	Patent 11484527 was granted and assigned to Allergan on November, 2022 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	11484527	November 1, 2022
‌ US Patent 11229627 Opioid receptor modulator dosage formulations	Patent 11229627 was granted and assigned to Allergan on January, 2022 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	11229627	January 25, 2022
‌ US Patent 8946281 Ketorolac tromethamine compositions for treating or preventing ocular pain	Patent 8946281 was granted and assigned to Allergan on February, 2015 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	8946281	February 3, 2015
‌ US Patent 10993996 Digestive enzyme composition suitable for enteral administration	Patent 10993996 was granted and assigned to Allergan on May, 2021 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10993996	May 4, 2021
‌ US Patent 9770453 Combination of brimonidine and timolol for topical ophthalmic use	Patent 9770453 was granted and assigned to Allergan on September, 2017 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	9770453	September 26, 2017
‌ US Patent 9820946 Pharmaceutical soft gelatin capsule dosage form with modified guar gum	Patent 9820946 was granted and assigned to Allergan on November, 2017 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	9820946	November 21, 2017
‌ US Patent 10472329 Process for the preparation of intermediates useful in the synthesis of Eluxadoline	Patent 10472329 was granted and assigned to Allergan on November, 2019 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10472329	November 12, 2019
‌ US Patent 10500215 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith	Patent 10500215 was granted and assigned to Allergan on December, 2019 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10500215	December 10, 2019
‌ US Patent 10188632 Opioid receptor modulator dosage formulations	Patent 10188632 was granted and assigned to Allergan on January, 2019 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10188632	January 29, 2019
‌ US Patent 11007179 Opioid receptor modulator dosage formulations	Patent 11007179 was granted and assigned to Allergan on May, 2021 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	11007179	May 18, 2021
‌ US Patent 11160792 Opioid receptor modulator dosage formulations	Patent 11160792 was granted and assigned to Allergan on November, 2021 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	11160792	November 2, 2021
‌ US Patent 10272061 Compositions and methods for unoccluded transdermal oxybutynin therapy	Patent 10272061 was granted and assigned to Allergan on April, 2019 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10272061	April 30, 2019
‌ US Patent 10137135 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith	Patent 10137135 was granted and assigned to Allergan on November, 2018 by the United States Patent and Trademark Office.		Allergan	United States Patent and Trademark Office	10137135	November 27, 2018
‌ US Patent 9763887 Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability	Patent 9763887 was granted and assigned to Allergan on September, 2017 by the United States Patent and Trademark Office.		Allergan	United States Patent and Trademark Office	9763887	September 19, 2017
‌ US Patent 9993424 Intravaginal matrix drug delivery devices	Patent 9993424 was granted and assigned to Allergan on June, 2018 by the United States Patent and Trademark Office.		Allergan	United States Patent and Trademark Office	9993424	June 12, 2018
‌ US Patent 9908682 Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavenger	Patent 9908682 was granted and assigned to Allergan on March, 2018 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	9908682	March 6, 2018
‌ US Patent 8377982 Ketorolac tromethamine compositions for treating or preventing ocular pain	Patent 8377982 was granted and assigned to Allergan on February, 2013 by the United States Patent and Trademark Office.		Allergan	United States Patent and Trademark Office	8377982	February 19, 2013
‌ US Patent 10184121 Methods for removing viral contaminants from pancreatic extracts	Patent 10184121 was granted and assigned to Allergan on January, 2019 by the United States Patent and Trademark Office.		Allergan	United States Patent and Trademark Office	10184121	January 22, 2019
‌ US Patent 9474751 Combination of brimonidine and timolol for topical ophthalmic use	Patent 9474751 was granted and assigned to Allergan on October, 2016 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	9474751	October 25, 2016
‌ US Patent 10702539 Ocular implant made by a double extrusion process		Allergan, Inc.	Allergan	United States Patent and Trademark Office	10702539	July 7, 2020
‌ US Patent 9216167 Ketorolac tromethamine compositions for treating or preventing ocular pain	Patent 9216167 was granted and assigned to Allergan on December, 2015 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	9216167	December 22, 2015
‌ US Patent 10433928 Multiple needle injector	Patent 10433928 was granted and assigned to Allergan on October, 2019 by the United States Patent and Trademark Office.	Allergan	Allergan	United States Patent and Trademark Office	10433928	October 8, 2019

Results per page:

47 results

0 selected

47 results

0 selected